Cash And Equivalent 更改
Gilead Sciences USD 8.43B 2.72B 2023-12
RedHill Biopharma USD 7M 10.58M 2023-06
Supernus Pharmaceuticals USD 75.05M 19.93M 2023-12



Intra Cellular Therapies 现金及等价物 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.